ID: ALA4876110
Max Phase: Preclinical
Molecular Formula: C14H8N2O6S
Molecular Weight: 332.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1c2ccccc2C(=O)N1S(=O)(=O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C14H8N2O6S/c17-13-11-3-1-2-4-12(11)14(18)15(13)23(21,22)10-7-5-9(6-8-10)16(19)20/h1-8H
Standard InChI Key: XKBXPAOROVRSIW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 332.29 | Molecular Weight (Monoisotopic): 332.0103 | AlogP: 1.58 | #Rotatable Bonds: 3 |
| Polar Surface Area: 114.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.23 | CX LogD: 2.23 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.48 | Np Likeness Score: -1.20 |
| 1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |
Source(1):
